FIGURE

Fig. 5

ID

ZDB-FIG-250407-31

Publication

Li et al., 2024 - Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation

Other Figures

All Figure Page

Back to All Figure Page

Fig. 5

DHE exhibited neuroprotective effects on SH-SY5Y cells against LPS-stimulated microglia-mediated neurotoxicity. (A, B) SH-SY5Y cells were treated with the indicated DHE (A) or LPS (B) concentrations. (C) SH-SY5Y cells were treated with conditioned medium from BV2 cells that had been exposed to 25–1000 ng/ml of LPS for 24 h, and the cell viability was detected by the MTT assay. (D) SH-SY5Y cells were treated with condition medium from BV2 microglia exposed to LPS (800 ng/ml) for 24 h after pretreatment with DHE (6, 12, 25 μM) for 1 h. The cell viability was detected by the MTT assay. (E) SH-SY5Y cells were co-cultured with BV2 cells in the presence of DHE (6, 12, 25 μM) for 1 h, followed by LPS stimulation for 24 h. Apoptosis was quantified by flow cytometry. Data are presented as the mean ± SD analyzed by one-way ANOVA. ∗p < 0.05 and ∗∗∗p < 0.001 vs. the LPS-treated group, ###p < 0.001 vs. the control group; n = 3.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Neurotherapeutics